Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Preclinical activity supports development of antiinfective acne treatment HB-1345

Aug. 6, 2008

No significant improvement in psoriasis lesions seen with PTH (1-34) in phase IIa study

Aug. 5, 2008

Ustekinumab improves nail psoriasis in phase III trial

Aug. 5, 2008

Alefacept found ineffective in treatment of severe alopecia areata

Aug. 5, 2008

FDA awards RegeneRx additional USD 136,000 for phase II trial of RGN-137 in EB

Aug. 4, 2008

FDA grants orphan drug designation to afamelanotide in erythropoietic porphyrias

Aug. 4, 2008

Efalizumab shows efficacy in the treatment of head and neck psoriasis

Aug. 4, 2008

Regulatory approval of Basilea's Toctino recommended under European decentralized procedure

July 31, 2008

MediGene's Oracea receives marketing authorization in Europe

July 30, 2008

Xoma commences phase IIa XOMA-629 study in patients with impetigo

July 28, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...